Login

Decibel Therapeutics, Inc. 4 SEC Filings

Filed On Filing
25 Sep 2023 Form 4: Trask Anna, Chief People Officer

Returned 106,864 shares to the issuer · Disposed of 234,802 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Carson William H., Director

Returned 5,000 shares to the issuer · Disposed of 35,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Lee John Jui-Jen, Chief Development Officer

Returned 147,144 shares to the issuer · Disposed of 329,503 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Finger Alison Cecily, Director

Returned 5,000 shares to the issuer · Disposed of 35,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Mclaughlin Kevin F, Director

Returned 5,000 shares to the issuer · Disposed of 25,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Reid Laurence, Director

Returned 220,849 shares to the issuer · Disposed of 1,332,039 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Kapusta Matthew C, Director

Returned 10,000 shares to the issuer · Disposed of 10,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Nochur Sara, Director

Returned 5,000 shares to the issuer · Disposed of 35,000 Stock Option (right to buy) (Disposition to Issuer)

14 Jun 2023 Form 4: Nochur Sara, Director

Received 5,000 shares as a grant or award · Granted 5,000 Stock Option (right to buy)

14 Jun 2023 Form 4: Carson William H., Director

Received 5,000 shares as a grant or award · Granted 5,000 Stock Option (right to buy)

14 Jun 2023 Form 4: Finger Alison Cecily, Director

Received 5,000 shares as a grant or award · Granted 5,000 Stock Option (right to buy)

14 Jun 2023 Form 4: Mclaughlin Kevin F, Director

Received 5,000 shares as a grant or award · Granted 5,000 Stock Option (right to buy)

21 Mar 2023 Form 4: Kapusta Matthew C, Director

Received 10,000 shares as a grant or award · Granted 10,000 Stock Options (right to buy)

17 Mar 2023 Form 4: Reid Laurence, Director

Received 195,000 shares as a grant or award · Granted 72,000 Stock Options (right to buy)

30 Jan 2023 Form 4: Trask Anna, Chief People Officer

Received 105,000 shares as a grant or award · Granted 45,000 Stock Options (right to buy)

30 Jan 2023 Form 4: Lee John Jui-Jen, Chief Development Officer

Received 120,000 shares as a grant or award · Granted 45,000 Stock Options (right to buy)

12 Oct 2022 Form 4: Mclaughlin Kevin F, Director

Granted 20,000 Stock Option (right to buy)

21 Jun 2022 Form 4: Finger Alison Cecily, Director

Granted 10,000 Stock Option (right to buy)

21 Jun 2022 Form 4: Carson William H., Director

Granted 10,000 Stock Option (right to buy)

21 Jun 2022 Form 4: Thompson Peter A., Director

Granted 10,000 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support